Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases
Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases RAPS
Regulatory Approvals
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma Oncodaily
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara PR Newswire
Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval
Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval Pharmaceutical Technology
Scholar Rock wins FDA approval for Isembyld
Scholar Rock wins FDA approval for Isembyld The Pharma Letter